Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adoptive Cord Blood ImmunotHerapy Using Expanded Cord Blood T Cells for EBV, CMV, BKV and Adenovirus Reactivation/Infection or ProphylaxiS

NCT03594981 is registered in ClinicalTrials.gov with Catherine Bollard as lead sponsor.

NCT NCT03594981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03594981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adoptive Cord Blood ImmunotHerapy Using Expanded Cord Blood T Cells for EBV, CMV, BKV and Adenovirus Reactivation/Infection or ProphylaxiS
Lead sponsor
Catherine Bollard
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
January 24, 2018
Completion date
December 15, 2026
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

viral infection